Pike CT - Search Results

1

The economic burden of adults with major depressive disorder in the United States (2005 and 2010).

Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. Greenberg PE, et al. Among authors: pike ct. J Clin Psychiatry. 2015 Feb;76(2):155-62. doi: 10.4088/JCP.14m09298. J Clin Psychiatry. 2015. PMID: 25742202 Free article.

2

Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US.

Pike C, Birnbaum HG, Schiller M, Swallow E, Burge RT, Edgell ET. Pike C, et al. Osteoporos Int. 2011 Jan;22(1):47-56. doi: 10.1007/s00198-010-1267-5. Epub 2010 May 20. Osteoporos Int. 2011. PMID: 20490782

3

Confounding factors in off-label drug use.

Greenberg PE, Pike C, Sisitsky T. Greenberg PE, et al. Health Aff (Millwood). 2012 Feb;31(2):460; author reply 460. doi: 10.1377/hlthaff.2011.1394. Health Aff (Millwood). 2012. PMID: 22323178 No abstract available.

4

Changes in utilization and costs for patients with rheumatoid arthritis, 1997 to 2006.

Birnbaum HG, Pike C, Banerjee R, Waldman T, Cifaldi M. Birnbaum HG, et al. Pharmacoeconomics. 2012 Apr;30(4):323-36. doi: 10.2165/11589470-000000000-00000. Pharmacoeconomics. 2012. PMID: 22379953

5

Societal cost of rheumatoid arthritis patients in the US.

Birnbaum H, Pike C, Kaufman R, Marynchenko M, Kidolezi Y, Cifaldi M. Birnbaum H, et al. Curr Med Res Opin. 2010 Jan;26(1):77-90. doi: 10.1185/03007990903422307. Curr Med Res Opin. 2010. PMID: 19908947

6

Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.

Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET. Pike C, et al. Pharmacoeconomics. 2010;28(5):395-409. doi: 10.2165/11531040-000000000-00000. Pharmacoeconomics. 2010. PMID: 20402541

7

Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US.

Pike CT, Birnbaum HG, Schiller M, Swallow E, Burge RT, Edgell ET. Pike CT, et al. Osteoporos Int. 2011 Oct;22(10):2611-21. doi: 10.1007/s00198-010-1494-9. Epub 2010 Nov 25. Osteoporos Int. 2011. PMID: 21107532

8

Workplace impacts of anti-TNF therapies in rheumatoid arthritis: review of the literature.

Birnbaum H, Shi L, Pike C, Kaufman R, Sun P, Cifaldi M. Birnbaum H, et al. Expert Opin Pharmacother. 2009 Feb;10(2):255-69. doi: 10.1517/14656560802682163. Expert Opin Pharmacother. 2009. PMID: 19236197 Review.

9

Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer.

Pike CT, Birnbaum HG, Muehlenbein CE, Pohl GM, Natale RB. Pike CT, et al. Chemother Res Pract. 2012;2012:913848. doi: 10.1155/2012/913848. Epub 2012 Mar 14. Chemother Res Pract. 2012. PMID: 22482054 Free PMC article.

10

Employer model of workplace impacts of anti-TNF therapy for rheumatoid arthritis.

Birnbaum H, Pike C, Kaufman R, Cifaldi M. Birnbaum H, et al. J Occup Environ Med. 2009 Oct;51(10):1167-76. doi: 10.1097/JOM.0b013e3181b8c397. J Occup Environ Med. 2009. PMID: 19786900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page